UK cost agency recommends Bayer, Regeneron eye drug

[riky]

UK cost agency recommends Bayer, Regeneron eye drug

LONDON (Reuters) - Britain's healthcare cost watchdog NICE is recommending a new eye drug from Bayer and Regeneron, after a price discount was offered for its use on the state health service. The draft decision by the National Institute for Health and Clinical Excellence (NICE) means Eylea will compete in Britain with Novartis's established product Lucentis as a treatment for wet age-related macular degeneration (AMD). Novartis already has a separate discount scheme in place for Lucentis. The size of the discounts offered on both drugs is commercially confidential. ...

Source: You are not allowed to view links. Register or Login